Stock listing
Protokinetix, Inc.
Selected listing: PKTX · OTC · USD · US
Protokinetix, Inc. (OTC:PKTX), Health Technology. Latest release Sep 3, 2026: ProtoKinetix Incorporated : Annual Report for Fiscal Year Ending December 31…
- Ticker
- OTC:PKTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Protokinetix, Inc.
The company focuses on developing innovative therapies and technologies. Protokinetix aims to advance its research and product offerings in the biotechnology sector.
Latest news from Protokinetix, Inc.
ProtoKinetix Incorporated : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
September 3, 2026
ProtoKinetix Incorporated : Initial Statement of Beneficial Ownership (Form 3)
July 28, 2026
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
June 5, 2023
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
July 20, 2022
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
January 14, 2022